Asia Pacific Automated Breast Ultrasound Systems Market Size By Product (Automated Breast Ultrasound Systems, Automated Breast Volume Scanner), By End-Use (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook (Japan, China, India, South Korea, Australia, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Published Date: September 2018 | Publisher: Graphical Research Report ID: GR1064 | Delivery : PDF

APAC Automated Breast Ultrasound Systems (ABUS) Market size was valued at USD  237.8 million in 2017 and is expected to witness 17.8% CAGR from 2018 to 2024.

 

China Automated Breast Ultrasound Systems Market, By Product, 2013-2024 (USD Million)
China Automated Breast Ultrasound Systems Market, By Product, 2013-2024 (USD Million)

 

Increasing incidence of breast cancer throughout the region will boost Asia Pacific automated breast ultrasound systems market growth in forthcoming period. China has recorded over 20% to 30% rise in breast cancer over last ten years, while high incidence rates are also witnessed in Australia and New Zealand. Factors such as environmental effects, obesity, hormonal changes, alcohol consumption and others further escalate the risk of developing breast cancer. Above factors are estimated to expand the adoption of ABUS across many countries in the region, thereby strengthening business growth.

Restricted capability of mammography systems to detect tumor in dense breasted patients will spur automated breast ultrasound industry growth over the forecast period. Asian women are 75-80% likely to be dense breasted. According to National Center for Biotechnology Information (NCBI), higher breast densities are observed in Chinese women. Hence, as a result of 3D imaging of dense breasts, tumor is easily diagnosed in ABUS. Aforementioned advantages over mammography will drive Asia Pacific ABUS market growth.

Automated breast volume scanner (ABVS) segment held significant market share of 41.8% in 2017. ABVS is advanced tool that consists of 3D worksation, flexible arm and touchscreen technology. It allows the physiscian to change the settings according to breast size. Such favourable and high-end features will attract significant segmental share in foreseeable years.

Hospitals segment accounted for largest revenue size of USD 144.6 million in 2017. High segmental size is attributable to availability of ABUS across many multi-specilaty hospitals. Hospitals throughout Asia Pacific have adopted ABUS due to its superior efficiency in screening dense breast tissues. For instance, Hokuto Hospital in Japan have utilised QVCAD systems as an investigational device for screening breast cancer. Growing acceptance of ABUS in hospitals will significantly stimulate segmental growth.

China automated breast ultrasound systems market will witness lucrative growth at 17.8% CAGR over the projected timeframe, owing to rising incidence of breast cancer and awareness across the country. Large number of women with dense breast tissues will assist fast adoption of ABUS. Government of China has initiated program towards promotion of ultrasound screening for breast cancer detection. This initiative is expected to generate higher demand for ABUS across hospitals and diagnostic centers of China.

Major industry players operating in automated breast ultrasound systemss market include GE Healthcare, Hitachi Ltd., Philips, Siemens AG, and SonoCine Inc. Firms are introducing novel products to strengthen product portfolio and increase customer base. For instance, in February 2014, Philips entered in partnership with SonoCine Inc., to provide automated whole breast (AWBUS) imaging for the Philips EPIQ and iU22 ultrasound systems. This partnership enabled the companies to provide quick and accurate automated whole breast ultrasound examinations for breast cancer.

Research on breast ultrasound was initiated in Japan and Australia in Asia Pacific region during 1950s and 1960s. Automated scanners were marketed in 1970s by certain companies such as Johnson and Johnson and Technicare Corporation, Australia.   Technologically advanced ABUS were developed widely by industry players to capture large profits. ABUS is being widely used recently in combination with mammography system for superlative screening of dense breasted women in hospitals and imaging centers. National screening programmes, awareness initiatives as well as limited capability of mammography systems will act as potential opportunities for Asia Pacific automated breast ultrasound systems industry in foreseeable years.

Segments Covered in this Report:

Asia Pacific Automated Breast Ultrasound Systems Market Share by Product

  • Automated Breast Ultrasound System (ABUS)
  • Automated Breast Volume Scanner (ABVS)
  • Others

Asia Pacific Automated Breast Ultrasound Systems Market Forecast by End-use

  • Hospitals
  • Diagnostic imaging centers

The above information is provided for the following countries:

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Malaysia
  • Indonesia
  • Thailand
  • Singapore
  • Taiwan
  • Philippines
  • Vietnam

Select License

APAC ABUS Market Outlook - Industry Growth Forecast Report 2018-24


Related Reports

Asia Pacific Dental Practice Management Software Market Size, Share, Report 2024

Europe DPMS Market by Component, Delivery Mode, Regional Outlook

North America Dental Practice Management Software Market 2018-2024

North America Cell Line Development Market Size, Share, Report 2024

Why Choose us?